Cargando…

Clinical and Prognostic Implications of 1p/19q, IDH, BRAF, MGMT Promoter, and TERT Promoter Alterations, and Expression of Ki-67 and p53 in Human Gliomas

BACKGROUND AND OBJECTIVE: Genetic alterations, including IDH, BRAF, and TERT promoter mutations (IDH-mu, BRAF-mu, TERTp-mu, respectively), 1p/19q co-deletion (1p/19q-codel), and MGMT promoter methylation (MGMTp-M), are correlated with glioma tumor development. Therefore, these genetic alterations co...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Zixi, Ling, Feng, Ruan, Sibei, Hu, Jiajia, Tang, Mingxi, Sun, Xingwang, Long, Wenbo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2021
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8627377/ https://www.ncbi.nlm.nih.gov/pubmed/34849029 http://dx.doi.org/10.2147/CMAR.S336213

Ejemplares similares

Evaluation of P57, P53 and Ki67 Expression in Meningiomas
por: Küçükosmanoğlu, İlknur, et al.
Publicado: (2022)

Significance of p53 and ki-67 expression in prostate cancer
por: Verma, Renuka, et al.
Publicado: (2015)

Prognostic role and interaction of TERT promoter status, telomere length and MGMT promoter methylation in newly diagnosed IDH wild-type glioblastoma patients
por: Giunco, S., et al.
Publicado: (2023)

P53, MAPK, topoisomerase II alpha and Ki67 immunohistochemical expression and KRAS/BRAF mutation in ovarian serous carcinomas
por: Sundov, Dinka, et al.
Publicado: (2013)

IMMUNOHISTOCHEMICAL ANALYSIS BY KI67 AND IDH1 IN PATIENTS WITH CHONDROSARCOMA
por: RIBEIRO, MARCELO BARBOSA, et al.
Publicado: (2023)

Expression of Cyclooxygenase-2, p53 and Ki-67 in Gastric Cancer
por: Joo, Young-Eun, et al.
Publicado: (2006)

Expression of p53 protein, PCNA, and Ki-67 in osteosarcomas of bone.
por: Park, H. R., et al.
Publicado: (1995)

Radiomic prediction models for the level of Ki-67 and p53 in glioma
por: Sun, Xiaojun, et al.
Publicado: (2020)

Immunoexpression of Ki67, p53 and cyclin D1 in osteosarcomas
por: Niculescu, Ştefan Adrian, et al.
Publicado: (2021)

Low expression of Ki-67/MIB-1 labeling index in IDH wild type glioblastoma predicts prolonged survival independently by MGMT methylation status
por: Tini, Paolo, et al.
Publicado: (2023)

Immunohistochemical Evaluation of p53 and Ki67 Expression in Skin Epithelial Tumors
por: Khodaeiani, Effat, et al.
Publicado: (2013)

General Clinico-Pathological Characteristics in Glioblastomas in Correlation with p53 and Ki67
por: Sipos, Tamás-Csaba, et al.
Publicado: (2023)

IDH mutation and MGMT promoter methylation in glioblastoma: results of a prospective registry
por: Yang, Pei, et al.
Publicado: (2015)

Prognostic Impact of the Combination of MGMT Methylation and TERT Promoter Mutation in Glioblastoma
por: Tunthanathip, Thara, et al.
Publicado: (2021)

Perfusion CT detects alterations in local cerebral flow of glioma related to IDH, MGMT and TERT status
por: Wang, Ke, et al.
Publicado: (2021)

The role of p53, PCNA and Ki–67 as outcome predictors in the treatment of laryngeal cancer
por: Sarafoleanu, D, et al.
Publicado: (2009)

P53 and Ki-67 as prognostic markers in triple-negative breast cancer patients
por: Pan, Yunbao, et al.
Publicado: (2017)

Immunohistochemical expression of P53, Ki-67, and CD34 in psoriasis and psoriasiform dermatitis
por: Ramezani, Mazaher, et al.
Publicado: (2019)

Ki67 and P53 Expression in Relation to Clinicopathological Features in Phyllodes Tumour of the Breast
por: Ali, Nurul Atiah Mohd, et al.
Publicado: (2020)

Expression of p53 and Ki-67 proteins in patients with increasing severity and duration of pterygium
por: Mahesh, Mood, et al.
Publicado: (2021)

Prognostic significance of CEA, Ki67 and p53 in pseudomyxoma peritonei of appendiceal origin
por: Yan, Fengcai, et al.
Publicado: (2021)

Spontaneous expression of the gene of KI67 and P53 in cynomolgus monkeys infected with papillomavirus
por: Darusman, Huda S., et al.
Publicado: (2022)

XGBoost Improves Classification of MGMT Promoter Methylation Status in IDH1 Wildtype Glioblastoma
por: Le, Nguyen Quoc Khanh, et al.
Publicado: (2020)

Predictive value of MGMT promoter methylation on the survival of TMZ treated IDH-mutant glioblastoma
por: Chai, Ruichao, et al.
Publicado: (2021)

Combining HPV DNA load with p16/Ki-67 staining to detect cervical precancerous lesions and predict the progression of CIN1–2 lesions
por: Li, Yuejie, et al.
Publicado: (2019)

Expression of p-16, Ki-67 and p-53 markers in dysplastic and malignant lesions of the oral cavity and oropharynx
por: Yadav, Priyanka, et al.
Publicado: (2019)

Expression of p53, p63, podoplanin and Ki-67 in recurring versus non-recurring oral leukoplakia
por: Sundberg, Jonas, et al.
Publicado: (2021)

The Role of P16, P53, KI-67 and PD-L1 Immunostaining in Primary Vaginal Cancer
por: Egger, Eva K., et al.
Publicado: (2023)

Clinicopathological and prognostic significance of Ki-67, caspase-3 and p53 expression in gastric carcinomas
por: XIAO, LI-JUN, et al.
Publicado: (2013)

Coexistence of HER2, Ki67, and p53 in Osteosarcoma: A Strong Prognostic Factor
por: Mardanpour, Keykhosro, et al.
Publicado: (2016)

Commentary: Expression of p53 and Ki-67 proteins in patients with increasing severity and duration of pterygium
por: Arora, Ritu
Publicado: (2021)

Comment on: Expression of p53 and Ki-67 proteins in patients with increasing severity and duration of pterygium
por: dos Santos Martins, Thiago Gonçalves
Publicado: (2021)

Prognostic value of the immunohistochemistry correlation of Ki-67 and p53 in squamous cell carcinomas of the larynx
por: Rodrigues, Ricardo Boose, et al.
Publicado: (2015)

Association of smoking, p53 and Ki-67 immunomarkers with bladder neoplasms in tribal region of India
por: Vaishnav, Mitsu, et al.
Publicado: (2022)

The genomic landscape of TERT promoter wildtype-IDH wildtype glioblastoma
por: Diplas, Bill H., et al.
Publicado: (2018)

P63 and Ki-67 expression in radicular cyst
por: Alsaegh, Mohammed Amjed, et al.
Publicado: (2023)

Immunohistochemical Expression of PD-L1 and IDH1 with Detection of MGMT Promoter Methylation in Astrocytoma
por: Hareedy, Amal Ahmed, et al.
Publicado: (2022)

Can p53, Ki-67 and bcl-2 predict biochemical failure after radical prostatectomy?
por: Baseskioglu, B., et al.
Publicado: (2010)

Ki-67 and p53 expression in solitary sporadic, syndrome associated and recurrent keratocystic odontogenic tumor
por: Alur, Jyoti, et al.
Publicado: (2014)

Breastfeeding and Immunohistochemical Expression of ki-67, p53 and BCL2 in Infiltrating Lobular Breast Carcinoma
por: Gonzalez-Sistal, Angel, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_lmapj2m3o2jb4cb0oo9mk4838c